Evaluation of Immunogenicity and Safety of COVID-19 Vaccine (Produced in Wuhan) in Patients With Hypertension and/or Diabetes

NCT05065892 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
1440
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

China National Biotec Group Company Limited

Collaborators